Authors:
Austin, NE
Avenell, KY
Boyfield, I
Branch, CL
Hadley, MS
Jeffrey, P
Johnson, CN
Macdonald, GJ
Nash, DJ
Riley, GJ
Smith, AB
Stemp, G
Thewlis, KM
Vong, AKK
Wood, MD
Citation: Ne. Austin et al., Design and synthesis of novel 2,3-dihydro-1H-isoindoles with high affinityand selectivity for the dopamine D-3 receptor, BIOORG MED, 11(5), 2001, pp. 685-688
Citation: T. Palfai et Md. Wood, Positive alcohol expectancies and drinking behavior: The influence of expectancy strength and memory accessibility, PSYCH ADDIC, 15(1), 2001, pp. 60-67
Authors:
Calver, AR
Robbins, MJ
Cosio, C
Rice, SQJ
Babbs, AJ
Hirst, WD
Boyfield, I
Wood, MD
Russell, RB
Price, GW
Couve, A
Moss, SJ
Pangalos, MN
Citation: Ar. Calver et al., The C-terminal domains of the GABA(B) receptor subunits mediate intracellular trafficking but are not required for receptor signaling, J NEUROSC, 21(4), 2001, pp. 1203-1210
Citation: Md. Wood et al., Social influence processes and college student drinking: The mediational role of alcohol outcome expectancies, J STUD ALC, 62(1), 2001, pp. 32-43
Authors:
Wood, MD
Reavill, C
Trail, B
Wilson, A
Stean, T
Kennett, GA
Lightowler, S
Blackburn, TP
Thomas, D
Gager, TL
Riley, G
Holland, V
Bromidge, SM
Forbes, IT
Middlemiss, DN
Citation: Md. Wood et al., SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety, NEUROPHARM, 41(2), 2001, pp. 186-199
Citation: Md. Wood, Religious studies as critical organic intellectual practice (Contributionstoward the struggle for social justice, ecological integrity, and human rights), J AM A REL, 69(1), 2001, pp. 129-162
Citation: Wk. Ward et al., Understanding spontaneous output fluctuations of an amperometric glucose sensor: Effect of inhalation anesthesia and use of a nonenzyme containing electrode, ASAIO J, 46(5), 2000, pp. 540-546
Authors:
Bromidge, SM
Dabbs, S
Davies, S
Duckworth, DM
Forbes, IT
Jones, GE
Jones, J
King, FD
Saunders, DV
Blackburn, TP
Holland, V
Kennett, GA
Lightowler, S
Middlemiss, DN
Riley, GJ
Trail, B
Wood, MD
Citation: Sm. Bromidge et al., 1-[2-[(heteroaryloxy)heteroaryl]carbamoyl]indolines: Novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/anxiolyticagents, BIOORG MED, 10(16), 2000, pp. 1863-1866
Authors:
Bromidge, SM
Davies, S
Duckworth, DM
Forbes, IT
Jones, GE
Jones, J
King, FD
Blackburn, TP
Holland, V
Kennett, GA
Lightowler, S
Middlemiss, DN
Riley, GJ
Trail, B
Wood, MD
Citation: Sm. Bromidge et al., 1-[2-[(heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orallyactive 5-HT2C receptor inverse agonists, BIOORG MED, 10(16), 2000, pp. 1867-1870
Citation: Wk. Ward et al., Rise in background current over time in a subcutaneous glucose sensor in the rabbit: relevance to calibration and accuracy, BIOSENS BIO, 15(1-2), 2000, pp. 53-61
Citation: Md. Wood et Kj. Sher, Risks of alcohol consumption in laboratory studies involving human research participants, PSYCH ADDIC, 14(4), 2000, pp. 328-334
Citation: Md. Wood et al., Collegiate alcohol involvement and role attaintment in early adulthood: Findings from a prospective high-risk study, J STUD ALC, 61(2), 2000, pp. 278-289
Authors:
Reavill, C
Taylor, SG
Wood, MD
Ashmeade, T
Austin, NE
Avenell, KY
Boyfield, I
Branch, CL
Cilia, J
Coldwell, MC
Hadley, MS
Hunter, AJ
Jeffrey, P
Jewitt, F
Johnson, CN
Jones, DNC
Medhurst, AD
Middlemiss, DN
Nash, DJ
Riley, GJ
Routledge, C
Stemp, G
Thewlis, KM
Trail, B
Vong, AKK
Hagan, JJ
Citation: C. Reavill et al., Pharmacological actions of a novel, high-affinity, and selective human dopamine D-3 receptor antagonist, SB-277011-A, J PHARM EXP, 294(3), 2000, pp. 1154-1165
Authors:
Bromidge, SM
Dabbs, S
Davies, DT
Davies, S
Duckworth, DM
Forbes, IT
Gaster, LM
Ham, P
Jones, GE
King, FD
Mulholland, KR
Saunders, DV
Wyman, PA
Blaney, FE
Clarke, SE
Blackburn, TP
Holland, V
Kennett, GA
Lightowler, S
Middlemiss, DN
Trail, B
Riley, GJ
Wood, MD
Citation: Sm. Bromidge et al., Biarylcarbamoylindolines are novel and selective 5-HT2C receptor inverse agonists: Identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent, J MED CHEM, 43(6), 2000, pp. 1123-1134
Authors:
Wood, MD
Boyfield, I
Nash, DJ
Jewitt, FR
Avenell, KY
Riley, GJ
Citation: Md. Wood et al., Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor, EUR J PHARM, 407(1-2), 2000, pp. 47-51
Authors:
Wood, MD
Murkitt, KL
Rice, SQ
Testa, T
Punia, PK
Stammers, M
Jenkins, O
Elshourbagy, NA
Shabon, U
Taylor, SJ
Gager, TL
Minton, J
Hirst, WD
Price, GW
Pangalos, M
Citation: Md. Wood et al., The human GABA(B1b) and GABA(B2) heterodimeric recombinant receptor shows low sensitivity to phaclofen and saclofen, BR J PHARM, 131(6), 2000, pp. 1050-1054
Authors:
Bromidge, SM
Dabbs, S
Davies, DT
Davies, S
Duckworth, DM
Forbes, IT
Gadre, A
Ham, P
Jones, GE
King, FD
Saunders, DV
Thewlis, KM
Vyas, D
Blackburn, TP
Holland, V
Kennett, GA
Riley, GJ
Wood, MD
Citation: Sm. Bromidge et al., Model studies on a synthetically facile series of N-substituted phenyl-N '-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT2C/2B receptor antagonists, BIO MED CH, 7(12), 1999, pp. 2767-2773
Authors:
Wood, MD
Murkitt, KL
Ho, M
Watson, JM
Brown, F
Hunter, AJ
Middlemiss, DN
Citation: Md. Wood et al., Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM(1), hM(2), hM(3), hM(4) and hM(5) using microphysiometry, BR J PHARM, 126(7), 1999, pp. 1620-1624